United Therapeutics (UTHR) Cash from Operations (QoQ) (2009 - 2026)
United Therapeutics (UTHR) Cash from Operations (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.97 Bn | 87.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn |
| 3 | Zoetis | 32.26 Bn | 30.32 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.15 Bn | 21.00 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.86 Bn | 16.55 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.82% |
| Dec 31, 2025 | -38.41% |
| Sep 30, 2025 | 193.22% |
| Jun 30, 2025 | -58.43% |
| Mar 31, 2025 | 35.17% |
| Dec 31, 2024 | -9.54% |
| Sep 30, 2024 | 62.45% |
| Jun 30, 2024 | -38.33% |
| Mar 31, 2024 | 149.83% |
| Dec 31, 2023 | -56.47% |
| Sep 30, 2023 | 225.68% |
| Jun 30, 2023 | -71.64% |
| Mar 31, 2023 | 192.36% |
| Dec 31, 2022 | -50.43% |
| Sep 30, 2022 | 103.62% |
| Jun 30, 2022 | -56.01% |
| Mar 31, 2022 | 65.35% |
| Dec 31, 2021 | -5.93% |
| Sep 30, 2021 | 25.24% |
| Jun 30, 2021 | 65.03% |